Niemann-Pick Disease
Co-Pay Relief Program Fund Notices
Would you like to be notified when any new funds open, or when any of our current funds re-open? If so, please sign up using the “Get Notified” link below. As a member of our subscriber community you will receive important news about all of our disease funds, so join today!
This fund has been developed in response to patients who have contacted PAF for help with their medication expenses and could not find help. While this fund has been fully designed and we are ready to provide needed support to these patient communities, this fund is not yet able to accept applications for assistance as we are still working to secure charitable donations that will allow us to open it.
If you, or someone you know, would like to contribute to this fund, please visit our Donors page for more information on how to provide critical support for patients in need.
Fund Type
- Co-pay, Co-insurance & Deductibles
- Office visits and administration charges related to treatment
- Medical Insurance premiums
$3,000 Per Year
- Household Income Requirements 400% or less of Federal Poverty Guideline (FPG) (adjusted for Cost of Living Index (COLI) and number in household)
- Insurance Requirements All Insurance Types
- Must reside and receive treatment in the United States.
About Niemann-Pick Disease
Niemann-Pick disease (NPD) is a group of inherited metabolic disorders known as lipid storage diseases that affects the body’s ability to metabolize fat, cholesterol and lipids. Harmful quantities of lipids accumulate in the spleen, liver, lungs, bone marrow and brain cells, causing progressive deterioration of the nervous system. NPD is divided according to the altered gene and symptoms. Niemann-Pick Types A (NPA) the most severe form, occurs in early infancy causing profound brain damage leading to an early death, is caused by mutations in the SMPD1 gene. Niemann-Pick Type B (NPB), also caused by mutations in the SMPD1 gene, usually occurs in pre-teen years with symptoms including ataxia and peripheral neuropathy, affects the liver, spleen and lungs, but generally does not affect the brain. Most people affected with NPB survive into adulthood. Niemann-Pick Type C (NPC) can appear at any age, is divided into Type C1, caused by a mutation in the NPC1 gene, affects the brain and gut; while Type C2, caused by a mutation in the NPC2 gene, is more severe than Type C1 but mostly affects the lungs. C2 have problems with speech and swallowing that worsen over time, eventually interfering with feeding. NPC individuals often experience progressive decline in intellectual function and about one-third have seizures. The majority of children with NPC die before age 20 and it is rare for any person with NPC to reach age 40.
Other names for this condition: lipid histiocytosis, neuronal cholesterol lipidosis, neuronal lipidosis, NPD, sphingomyelin lipidosis, sphingomyelin/cholesterol lipidosis and sphingomyelinase deficiency
- Ara Parseghian Medical Research Foundation
- Genetic and Rare Diseases (GARD) Information Center
- Hide & Seek Foundation
- National Center for Biotechnology Information
- National Institute of Neurological Disorders and Stroke
- National Niemann-Pick Disease Foundation, Inc.877-287-3672
- NNPDF Emergency Hardship Program
- CancerCare866-55-COPAY
- Good Days877-968-7233
- Healthwell Foundation800-675-8416
- National Organization for Rare Disorders800-999-6673
- Needy Meds800-503-6897
- Patient Access Network Foundation866-316-7263
- Patient Services Inc.800-366-7741
- The Assistance Fund855-845-3663
